Management of Frequent Ventricular Extrasystoles Associated with Cardiogenic Syncope

Introduction to Guideline Recommendations

The American College of Cardiology recommends that frequent ventricular extrasystoles (EVF) associated with cardiogenic syncope require urgent evaluation of underlying structural heart disease, optimization of hemodynamics if indicated, and consideration of catheter ablation when EVF act as triggers for malignant ventricular arrhythmias, especially if the frequency exceeds 10,000-20,000 per day 1, 2, 3

The European Heart Journal suggests that an ECG should identify the morphology of EVF, duration of the QRS, and evidence of structural heart disease 4
The American College of Cardiology recommends echocardiography to evaluate ventricular function, structural anomalies, diastolic dysfunction, and pulmonary hypertension 1
The American College of Cardiology also recommends 24-hour Holter monitoring to quantify the EVF burden (target: >10,000-20,000/day suggests risk of cardiomyopathy) 3

The American College of Cardiology identifies the presence of underlying structural heart disease (ischemic, cardiomyopathy, valvular, congenital) as a critical risk factor 1, 3
The American College of Cardiology also notes that EVF with complex or polymorphic morphology 3, EVF occurring during exercise or post-exercise recovery 3, and left ventricular dysfunction with LVEF ≤40% 1, 3 are significant risk factors

The European Heart Journal recommends beta-blockers as first-line therapy to suppress symptomatic EVF and reduce arrhythmic risk 5, 6
The European Heart Journal suggests amiodarone for recurrent ventricular tachycardia or fibrillation when beta-blockers are insufficient 5
The European Heart Journal also recommends verapamil for idiopathic left ventricular fascicular tachycardia 2

The European Heart Journal indicates that catheter ablation is strongly recommended (Class I) for EVF triggering recurrent ventricular fibrillation with ICD discharges 2, electrical storm due to EVF triggers 2, and left ventricular fascicular tachycardia in experienced centers 2
The American College of Cardiology recommends catheter ablation for frequent or complex EVF in repaired tetralogy of Fallot with unexplained syncope 1, and for EVF-induced cardiomyopathy (burden >10,000-20,000/day with ventricular dysfunction) 3

The American College of Cardiology recommends ICD implantation for survivors of cardiac arrest due to ventricular fibrillation or tachycardia with LVEF ≤40% 3, 6
The American College of Cardiology also recommends ICD implantation for secondary prevention in patients with symptomatic sustained ventricular tachycardia 3

The European Heart Journal recommends cardioversion/electrical defibrillation as the intervention of choice for acute ventricular tachycardia or fibrillation 5
The European Heart Journal suggests early intravenous beta-blockers to prevent recurrent arrhythmias 5
The European Heart Journal also recommends considering immediate angiography for recurrent polymorphic ventricular tachycardia or fibrillation indicating incomplete revascularization or recurrent ischemia 5

Syncope is primarily caused by transient global cerebral hypoperfusion resulting from decreased cardiac output, reduced peripheral vascular resistance, or both, with neurally-mediated reflexes, cardiac conditions, and orthostatic issues being the most common etiologies 7, 8
Vasovagal syncope, also known as common faint, is triggered by emotional stress, pain, or prolonged standing, characterized by inappropriate vasodilation and bradycardia, as stated by the European Society of Cardiology 7, 9
Carotid sinus syncope occurs with mechanical manipulation of carotid sinuses, according to the European Heart Journal 7, 8
Situational syncope is associated with specific triggers such as acute hemorrhage, coughing or sneezing, gastrointestinal stimulation, micturition, post-exercise, and others, as reported by the European Heart Journal 8, 9

Cardiac arrhythmias, including sinus node dysfunction, atrioventricular conduction system disease, paroxysmal supraventricular and ventricular tachycardias, and inherited syndromes like long QT syndrome and Brugada syndrome, can cause syncope, as stated by the European Heart Journal 7, 8
Structural cardiac or cardiopulmonary disease, such as cardiac valvular disease, acute myocardial infarction/ischemia, obstructive cardiomyopathy, atrial myxoma, acute aortic dissection, pericardial disease/tamponade, and pulmonary embolus/pulmonary hypertension, can also lead to syncope, according to the European Heart Journal 7, 8, 10, 11

High-risk features requiring hospitalization include suspected or known significant heart disease, ECG abnormalities suggesting arrhythmic syncope, syncope during exercise, syncope causing severe injury, and family history of sudden death, as recommended by the European Society of Cardiology 11, 12
Neurological evaluation is only necessary when loss of consciousness cannot be attributed to syncope, as stated by the European Heart Journal 7

Treatment of structural cardiac disease is directed at the underlying cardiac condition, including valve repair/replacement for valvular disease, revascularization for ischemic heart disease, surgical myectomy or alcohol septal ablation for obstructive cardiomyopathy, and surgical removal of cardiac masses, as reported by the European Heart Journal 10, 11
Vascular steal syndromes, such as subclavian steal syndrome, can be treated with direct corrective angioplasty or surgery, according to the European Heart Journal 10, 11

Cardiac syncope carries a higher mortality risk compared to non-cardiac causes, with a 24% one-year mortality rate, as stated by the European Heart Journal 8
Multiple mechanisms may contribute to syncope in patients with structural heart disease, as reported by the European Heart Journal 13
Avoid unnecessary neurological testing unless specific neurological signs are present, as recommended by the European Society of Cardiology 7